CANNABIS AS PAINKILLER

Canada has become the first country in the world to approve the sale
of a cannabis-based prescription painkiller. Cannabis sativa L. has
won approval by Health Canada regulators for treatment of severe pain
common among sufferers of multiple sclerosis, but it may also find
favor with those with nerve pain related to other conditions. The
drug, marketed in Canada by Bayer HealthCare under the brand name
Sativex, contains the active ingredients that give pot smokers their
buzz, including delta-9-tetrahydrocannabinol (THC) and cannabidiol
(CBD).